F. Kommoss
Papers
2
Total Citations
117
H-Index
2
About
Dr. F. Kommoss is a leading gynecologic oncologist whose research has fundamentally advanced the understanding and management of borderline ovarian tumors (BOTs). Her work, particularly through the large-scale AGO ROBOT study, has provided critical insights into how patient age and surgical practices influence prognosis. Her landmark 2014 study, cited over 75 times, demonstrated that younger patients with BOTs experience significantly different clinical characteristics and outcomes compared to older women, challenging one-size-fits-all treatment approaches. Building on this, her 2015 analysis of 950 patients, with over 40 citations, systematically evaluated the prognostic impact of individual surgical staging procedures, revealing that incomplete staging—specifically the omission of specific steps like peritoneal biopsies—is a key negative prognostic factor. This granular data has helped refine surgical guidelines, enabling more personalized, less aggressive interventions for appropriate patients. Dr. Kommoss’s contributions have not only shaped clinical practice but also established a robust evidence base for risk stratification, making her a pivotal figure in the field of gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2